XML 30 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events
9 Months Ended
Sep. 30, 2022
Subsequent Events.  
Subsequent Events

11. Subsequent Events

In November 2022, the Company announced plans to stop further clinical development of PBKR03 for Krabbe disease. Additionally, the Company announced a 23 percent reduction to its workforce, which will result in severance related expenses within the three months ending December 31, 2022.